On June 14, we will investigate the realm of psychedelics with Dr. Franklin King. There has been much reported in media lately about the impact of psilocybin (mushrooms) and MDMA (ecstasy) for mental health and pain. The session will explore the history of the drugs and discuss existing evidence-based research on their recommended use.
- Dr. Franklin King is the director of training and education at the Mass General Center for the Neuroscience of Psychedelics and a clinical instructor at Harvard Medical School. His primary clinical and research interest is in the utilization of psychedelic-assisted psychotherapy to treat a variety of chronic psychiatric conditions, including depression and anxiety disorders, and in strategies to optimize these interventions for different patient populations.